Download now Free registration required
The biotechnology and pharmaceutical industry is one of the fastest growing wealth-producing sectors in the US economy and the second most frequently targeted industry in 2011. Biotechnology and pharmaceutical manufacturers overall face greater security risks with insider threats and bio-espionage attacks than other industries. Aside from the significant value of patents, intellectual property, clinical trial data, and large volumes of protected health information (PHI) generated from clinical trial research, there are also security risks associated with data sharing among third-party partnerships.
- Format: PDF
- Size: 842.4 KB